4//SEC Filing
De Backer Marianne 4
Accession 0001209191-22-001323
CIK 0000879407other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:31 PM ET
Size
9.2 KB
Accession
0001209191-22-001323
Insider Transaction Report
Form 4
De Backer Marianne
Director
Transactions
- Sale
Common Stock
2022-01-03$64.25/sh−2,244$144,177→ 19,256 total - Sale
Common Stock
2022-01-03$65.01/sh−1,984$128,980→ 17,272 total - Sale
Common Stock
2022-01-03$66.25/sh−272$18,020→ 17,000 total
Footnotes (3)
- [F1]The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.72 to $64.69, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.73 to $65.57, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001797819
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:31 PM ET
- Size
- 9.2 KB